Trade-Ideas LLC identified

Vascular Solutions

(

VASC

) as a strong and under the radar candidate. In addition to specific proprietary factors, Trade-Ideas identified Vascular Solutions as such a stock due to the following factors:

  • VASC has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $3.1 million.
  • VASC has traded 6.3880999999999996674659996642731130123138427734375 options contracts today.
  • VASC is making at least a new 3-day high.
  • VASC has a PE ratio of 48.
  • VASC is mentioned 0.55 times per day on StockTwits.
  • VASC has not yet been mentioned on StockTwits today.
  • VASC is currently in the upper 20% of its 1-year range.
  • VASC is in the upper 35% of its 20-day range.
  • VASC is in the upper 45% of its 5-day range.
  • VASC is currently trading above yesterday's high.

TheStreet Recommends

'Strong and Under the Radar' stocks tend to be worthwhile stocks to watch for a variety of factors including historical back testing and price action. Market technicians refer to such stocks as being in an accumulation phase before a mark-up and peak. Traders and hedge funds have frequently found that these types of stocks continue to build a solid price base and then ultimately spike higher and peak when others 'discover' how good the stock is performing. By leveraging the social discovery aspect of StockTwits we are highlighting stocks that don't currently receive much attention from retail investors, but we suspect may soon garner more attention.

EXCLUSIVE OFFER: Get the inside scoop on opportunities in VASC with the Ticky from Trade-Ideas. See the FREE profile for VASC NOW at Trade-Ideas

More details on VASC:

Vascular Solutions, Inc., a medical device company, provides various solutions to interventional cardiologists, interventional radiologists, electro physiologists, and vein practices worldwide. VASC has a PE ratio of 48. Currently there are 3 analysts that rate Vascular Solutions a buy, no analysts rate it a sell, and none rate it a hold.

The average volume for Vascular Solutions has been 100,300 shares per day over the past 30 days. Vascular has a market cap of $595.1 million and is part of the health care sector and health services industry. The stock has a beta of 0.70 and a short float of 3.5% with 7.10 days to cover. Shares are up 26.4% year-to-date as of the close of trading on Monday.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

TheStreetRatings.com

Analysis:

TheStreet Quant Ratings

rates Vascular Solutions as a

buy

. The company's strengths can be seen in multiple areas, such as its growth in earnings per share, increase in net income, robust revenue growth, largely solid financial position with reasonable debt levels by most measures and good cash flow from operations. We feel its strengths outweigh the fact that the company has had somewhat disappointing return on equity.

Highlights from the ratings report include:

  • VASCULAR SOLUTIONS INC has improved earnings per share by 6.7% in the most recent quarter compared to the same quarter a year ago. The company has demonstrated a pattern of positive earnings per share growth over the past year. We feel that this trend should continue. During the past fiscal year, VASCULAR SOLUTIONS INC increased its bottom line by earning $0.72 versus $0.66 in the prior year. This year, the market expects an improvement in earnings ($1.04 versus $0.72).
  • The net income growth from the same quarter one year ago has significantly exceeded that of the S&P 500 and the Health Care Equipment & Supplies industry. The net income increased by 15.6% when compared to the same quarter one year prior, going from $2.57 million to $2.97 million.
  • VASC's revenue growth trails the industry average of 30.2%. Since the same quarter one year prior, revenues rose by 15.7%. This growth in revenue appears to have trickled down to the company's bottom line, improving the earnings per share.
  • VASC has no debt to speak of therefore resulting in a debt-to-equity ratio of zero, which we consider to be a relatively favorable sign. Along with this, the company maintains a quick ratio of 3.36, which clearly demonstrates the ability to cover short-term cash needs.
  • Net operating cash flow has slightly increased to $6.88 million or 1.51% when compared to the same quarter last year. In addition, VASCULAR SOLUTIONS INC has also modestly surpassed the industry average cash flow growth rate of -3.75%.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.